FDA Full FAERS Reports – IZERVAY/Avacincaptad Pegol Intravitreal Solution (Nov 23–29, 2024; Electronic)

FDA Full FAERS Reports – IZERVAY/Avacincaptad Pegol Intravitreal Solution (Nov 23–29, 2024; Electronic)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request Contents: Full FAERS reports for IZERVAY (marketed by Astellas Pharma Inc.) or avacincaptad pegol intravitreal solution (generic) for November 23–29, 2024, electronically
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details